Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 13th Aug 2012 08:16
AMEC: HSBC cuts target from 1,280p to 1,275p, overweight rating kept.Aviva: Exane BNP Paribas downgrades to neutral.British American Tobacco: Nomura keeps buy rating and 3,390p target.British Land: JPMorgan Cazenove ups target from 560p to 610p, overweight rating kept.BSkyB: Nomura maintains buy rating and 950p target; Goldman Sachs raises target from 837p to 890p, conviction buy rating maintained.Centrica: Credit Suisse downgrades to neutral, target cut from 370p to 330p.Diageo: Deutsche Bank downgrades to hold, target raised from 2,200p to 2,350p.ENRC: UBS cuts target from 615p to 585p, buy rating kept.Experian: Nomura reiterates buy rating and 1,035p target.FirstGroup: Goldman Sachs upgrades to conviction buy, target upped from 300p to 360p.FlyBe: HSBC cuts target from 90p to 80p, overweight rating kept.G4S: UBS keeps neutral rating and 280p target.GlaxoSmithKline: Jefferies downgrades from buy to hold, target cut from 1,600p to 1,550p.Hammerson: JPMorgan Cazenove ups target from 500p to 535p, overweight rating kept.Hargreaves Services: Westhouse Securities initiates coverage with buy rating.Imperial Tobacco: Nomura keeps neutral rating and 2,197p target.Tullow Oil: Bernstein cuts target from 2,140p to 1,920p, outperform rating kept.Whitbread: Deutsche Bank downgrades to hold, target lifted from 2,200p to 2,350p.BC Tullow Oil Aviva British Land Centrica Experian British American Tobacco Diageo Hargreaves Serv Hammerson Glaxosmithkline Whitbread Firstgroup

Shares in this article

Related News

Whitbread secures approval for Norwich city centre development scheme
4 hours ago

Whitbread secures approval for Norwich city centre development scheme

(Alliance News) - Whitbread PLC on Thursday said it had secured planning approval for the development of its Norwich Nelson site.

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
9 hours ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

Market News Astrazeneca + 12 more shares